Comparable stake leader
BAKER BROS. ADVISORS LP
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000879169.
Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
50/50
Latest evidence
07 May 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13D/G
3/4/5
13F
Felix J. Baker · Director, 10%+ Owner · Company
|
16%
|
$3,027,631,461
31,225,572 shares
|
+$1,178,549 | 07 May 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
7.8%
from 13D/G
|
$1,786,227,957
18,978,198 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
6.3%
|
$1,185,124,216
12,591,630 shares
|
$0 | 31 Mar 2026 |
| DODGE & COX |
13D/G
13F
Company
|
6.2%
|
$1,187,988,438
12,252,356 shares
|
$0 | 31 Mar 2026 |
| STATE STREET CORP |
13F
13D/G
Company · STATE STREET CORPORATION
|
5%
from 13D/G
|
$907,447,062
9,641,384 shares
|
— | 31 Mar 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
Company
|
3.9%
|
$730,294,304
7,759,183 shares
|
— | 31 Mar 2026 |
| AQR CAPITAL MANAGEMENT LLC |
13F
Company
|
2.9%
|
$536,130,025
5,807,930 shares
|
— | 31 Mar 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
2.4%
|
$441,081,113
4,703,184 shares
|
— | 31 Mar 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to selling over the last 12 months. Net value: -$43,539,286.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 38,357 | $0 | $3,688,880 | -$3,688,880 |
| 3-6 | 0 | 63,825 | $0 | $6,417,008 | -$6,417,008 |
| 6-9 | 0 | 292,006 | $0 | $30,032,558 | -$30,032,558 |
| 9-12 | 0 | 49,335 | $0 | $3,400,841 | -$3,400,841 |
Reporting owners
Showing 1-20 of 38 reporting-owner rows connected to INCYTE CORP. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Julian C. Baker | Director, 10%+ Owner | $2,681,154,085 | Median | 08 Jun 2026 | ||
| 667, L.P. | Director, 10%+ Owner | $2,681,154,085 | Median | 08 Jun 2026 | ||
| Baker Bros. Advisors (GP) LLC | Director, 10%+ Owner | $2,681,154,085 | Median | 08 Jun 2026 | ||
| Felix Baker | Director, 10%+ Owner | $2,681,154,085 | Median | 08 Jun 2026 | ||
| BAKER BROS. ADVISORS LP | Director, 10%+ Owner | $2,681,154,085 | Median | 08 Jun 2026 | ||
| Baker Brothers Life Sciences LP | Director, 10%+ Owner | $2,681,154,085 | Median | 08 Jun 2026 | ||
| Herve Hoppenot | Director | $31,601,850 | -$19,773,750 | -38% | Mixed | 08 Dec 2025 |
| Pablo J. Cagnoni | President, Global Head of R&D | $22,668,613 | -$5,444,331 | -19% | Median | 01 Jun 2026 |
| William Meury | Chief Executive Officer, Director, President | $15,162,826 | Median | 15 Apr 2026 | ||
| Christiana Stamoulis | EVP & Chief Financial Officer | $8,564,187 | Mixed | 14 Jul 2025 | ||
| Steven H. Stein | CMO & Head of Late-Stage Dev. | $7,372,137 | -$5,724,778 | -44% | Median | 06 May 2026 |
| Paula J. Swain | EVP, Human Resources | $7,251,424 | Mixed | 14 Jul 2025 | ||
| Mohamed Khairie Issa | EVP, Head of US Oncology | $7,213,017 | -$1,184,064 | -14% | Filing P/S | 16 Jan 2026 |
| Wenqing Yao | EVP, Head of Discovery Chem | $6,062,363 | Mixed | 02 Jul 2021 | ||
| Patrick A. Mayes | EVP & Chief Scientific Officer | $5,697,444 | -$554,965 | -8.9% | Filing P/S | 16 Jan 2026 |
| Maria E. Pasquale | EVP & General Counsel | $4,288,026 | Mixed | 14 Jul 2023 | ||
| Lee Heeson | EVP, Head of Incyte Intl | $3,905,669 | -$289,017 | -6.9% | Mixed | 02 Feb 2026 |
| Dashyant Dhanak | EVP & Chief Scientific Officer | $3,626,532 | Mixed | 14 Jul 2023 | ||
| Michael James Morrissey | EVP, Head of Tech. Operations | $3,497,453 | -$5,675,002 | -62% | Mixed | 02 Feb 2026 |
| Sheila A. Denton | EVP & General Counsel | $2,772,740 | -$935,863 | -25% | Filing P/S | 17 Nov 2025 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | INCY | Common Stock | Award | 0.01% | 3,284 | 28,205,360 | 08 Jun 2026 | See Footnotes | ||
| BAKER BROS. ADVISORS LP | INCY | Common Stock | Award | 0.01% | 3,284 | 28,205,360 | 08 Jun 2026 | See Footnotes | ||
| Baker Bros. Advisors Lp | INCY | Common Stock | Award | 0.01% | 3,284 | 28,205,360 | 08 Jun 2026 | See Footnotes | ||
| Baker Bros. Advisors Lp | INCY | Common Stock | Award | 0.01% | 3,284 | 28,205,360 | 08 Jun 2026 | See Footnotes | ||
| BAKER BROS. ADVISORS LP | INCY | Common Stock | Award | 0.01% | 3,284 | 28,205,360 | 08 Jun 2026 | See Footnotes | ||
| Baker Bros. Advisors Lp | INCY | Common Stock | Award | 0.01% | 3,284 | 28,205,360 | 08 Jun 2026 | See Footnotes | ||
| BAKER BROS. ADVISORS LP | INCY | Non-Qualified Stock Options (right to buy) | Award | 12,222 | 6,111 | 08 Jun 2026 | See Footnotes | |||
| BAKER BROS. ADVISORS LP | INCY | Non-Qualified Stock Options (right to buy) | Award | 12,222 | 6,111 | 08 Jun 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | INCY | Non-Qualified Stock Options (right to buy) | Award | 12,222 | 6,111 | 08 Jun 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | INCY | Non-Qualified Stock Options (right to buy) | Award | 12,222 | 6,111 | 08 Jun 2026 | See Footnotes | |||
| BAKER BROS. ADVISORS LP | INCY | Non-Qualified Stock Options (right to buy) | Award | 12,222 | 6,111 | 08 Jun 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | INCY | Non-Qualified Stock Options (right to buy) | Award | 12,222 | 6,111 | 08 Jun 2026 | See Footnotes | |||
| Edmund Harrigan | INCY | Common Stock | Award | 7.77% | 1,642 | 22,764 | 08 Jun 2026 | Direct | ||
| Edmund Harrigan | INCY | Non Qualfied Stock Option (right to buy) | Award | 6,111 | 6,111 | 08 Jun 2026 | Direct | |||
| Paul J. Clancy | INCY | Common Stock | Award | 6.92% | 1,642 | 25,383 | 08 Jun 2026 | Direct | ||
| Paul J. Clancy | INCY | Non Qualfied Stock Option (right to buy) | Award | 6,111 | 6,111 | 08 Jun 2026 | Direct | |||
| Jacqualyn A. Fouse | INCY | Common Stock | Award | 8.5% | 1,642 | 20,968 | 08 Jun 2026 | Direct | ||
| Jacqualyn A. Fouse | INCY | Non Qualfied Stock Option (right to buy) | Award | 6,111 | 6,111 | 08 Jun 2026 | Direct | |||
| Jean Jacques Bienaime | INCY | Common Stock | Award | 7.21% | 1,642 | 24,424 | 08 Jun 2026 | Direct | ||
| Jean Jacques Bienaime | INCY | Non Qualfied Stock Option (right to buy) | Award | 6,111 | 6,111 | 08 Jun 2026 | Direct | |||
| Katherine A. High | INCY | Common Stock | Award | 12.3% | 1,642 | 14,983 | 08 Jun 2026 | Direct | ||
| Katherine A. High | INCY | Non Qualfied Stock Option (right to buy) | Award | 6,111 | 6,111 | 08 Jun 2026 | Direct | |||
| Otis W. Brawley | INCY | Common Stock | Award | 14.6% | 1,642 | 12,894 | 08 Jun 2026 | Direct | ||
| Otis W. Brawley | INCY | Non Qualfied Stock Option (right to buy) | Award | 6,111 | 6,111 | 08 Jun 2026 | Direct | |||
| Thomas Tray | INCY | Common Stock | Sale | -11.1% | $263,900 | $100.00 | -2,639 | 21,132 | 04 Jun 2026 | Direct |
| Thomas Tray | INCY | Common Stock | Options Exercise | 12.5% | 2,639 | 23,771 | 04 Jun 2026 | Direct | ||
| Thomas Tray | INCY | Non-Qualified Stock Option (right to buy) | Options Exercise | -100% | -2,639 | 0 | 04 Jun 2026 | Direct | ||
| Pablo J. Cagnoni | INCY | Common Stock | Tax liability | -9.56% | -25,469 | 240,848 | 01 Jun 2026 | Direct | ||
| Thomas Tray | INCY | Common Stock | Sale | -8.85% | $199,665 | $97.35 | -2,051 | 21,132 | 26 May 2026 | Direct |
| Jean Jacques Bienaime | INCY | Common Stock | Tax liability | -36.4% | -13,059 | 22,782 | 26 May 2026 | Direct | ||
| Jean Jacques Bienaime | INCY | Common Stock | Options Exercise | 72% | 15,000 | 35,841 | 26 May 2026 | Direct | ||
| Jean Jacques Bienaime | INCY | Non-Qualified Stock Option (right to buy) | Options Exercise | -100% | -15,000 | 0 | 26 May 2026 | Direct | ||
| Paul J. Clancy | INCY | Common Stock | Sale | -38.7% | $1,423,950 | $94.93 | -15,000 | 23,741 | 19 May 2026 | Direct |
| Paul J. Clancy | INCY | Common Stock | Options Exercise | 63.2% | 15,000 | 38,741 | 19 May 2026 | Direct | ||
| Paul J. Clancy | INCY | Non-Qualified Stock Option (right to buy) | Options Exercise | -100% | -15,000 | 0 | 19 May 2026 | Direct | ||
| BAKER BROS. ADVISORS LP | INCY | Common Stock | Options Exercise | 0.11% | 30,000 | 28,203,718 | 08 May 2026 | See Footnotes | ||
| BAKER BROS. ADVISORS LP | INCY | Common Stock | Options Exercise | 0.11% | 30,000 | 28,203,718 | 08 May 2026 | See Footnotes | ||
| Baker Bros. Advisors Lp | INCY | Common Stock | Options Exercise | 0.11% | 30,000 | 28,203,718 | 08 May 2026 | See Footnotes | ||
| Baker Bros. Advisors Lp | INCY | Common Stock | Options Exercise | 0.11% | 30,000 | 28,203,718 | 08 May 2026 | See Footnotes | ||
| BAKER BROS. ADVISORS LP | INCY | Common Stock | Options Exercise | 0.11% | 30,000 | 28,203,718 | 08 May 2026 | See Footnotes | ||
| Baker Bros. Advisors Lp | INCY | Common Stock | Options Exercise | 0.11% | 30,000 | 28,203,718 | 08 May 2026 | See Footnotes | ||
| BAKER BROS. ADVISORS LP | INCY | Non-Qualified Stock Options | Options Exercise | -100% | -30,000 | 0 | 08 May 2026 | See Footnotes | ||
| BAKER BROS. ADVISORS LP | INCY | Non-Qualified Stock Options | Options Exercise | -100% | -30,000 | 0 | 08 May 2026 | See Footnotes | ||
| Baker Bros. Advisors Lp | INCY | Non-Qualified Stock Options | Options Exercise | -100% | -30,000 | 0 | 08 May 2026 | See Footnotes | ||
| Baker Bros. Advisors Lp | INCY | Non-Qualified Stock Options | Options Exercise | -100% | -30,000 | 0 | 08 May 2026 | See Footnotes | ||
| BAKER BROS. ADVISORS LP | INCY | Non-Qualified Stock Options | Options Exercise | -100% | -30,000 | 0 | 08 May 2026 | See Footnotes | ||
| Baker Bros. Advisors Lp | INCY | Non-Qualified Stock Options | Options Exercise | -100% | -30,000 | 0 | 08 May 2026 | See Footnotes | ||
| Steven H. Stein | INCY | Common Stock | Award | 129% | 44,124 | 78,327 | 06 May 2026 | Direct | ||
| Pablo J. Cagnoni | INCY | Common Stock | Award | 13.4% | 31,517 | 266,317 | 06 May 2026 | Direct | ||
| Suketu Upadhyay | INCY | Common Stock | Award | 26,343 | 26,343 | 04 May 2026 | Direct |